| Literature DB >> 32483266 |
Alfredo Santovito1, Claudio Gendusa2, Piero Cervella2, Deborah Traversi3.
Abstract
Urban air pollution represents a global problem, since everyday many mutagenic and carcinogens compounds are emitted into the atmosphere, with consequent adverse health effects on humans and biota. Specifically, particulate matter air pollution was associated with increased risks in human mortality and morbidity. In this paper, we analyse the genomic effects on human lymphocytes of different concentrations of annual Turin PM2.5 extract by an in vitro micronuclei assay. Samplings were collected from an urban meteorological-chemical station positioned in Turin (Italy), one of the most polluted cities in Europe. PM2.5 sampled on filters was used for organic extraction in monthly pools and successively aggregated to produce a mixture representative for a full year PM2.5 collection. Lymphocytes were exposed to four concentrations of PM2.5: 5, 10, 15 and 20 μg/mL and micronuclei, nucleoplasmic bridges and nuclear buds were scored. With respect to controls, PM2.5 significantly increased the frequencies of all analysed biomarkers at all tested concentrations, whereas the CBPI index was significantly reduced only at the concentration of 20 μg/mL. Such in vitro effects can both to stimulate local authorities to adopt efficient measures for air pollution mitigation and to improve human monitoring to detect early precancer lesions.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32483266 PMCID: PMC7264132 DOI: 10.1038/s41598-020-65785-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
PM2.5 pollution level recorded in Turin (adapted from Città metropolitana di Torino, 2019 and ARPA, 2018)[51,52].
| Year | Mean mass (µg/m3) | Mean Particles number (particles/m3) |
|---|---|---|
| 2014 | 25 | 9.0 × 109 |
| 2015 | 30 | 9.4 × 109 |
| 2015 (involved sample) | 42 | — |
| 2016 | 24 | 8.1 × 109 |
| 2017 | 27 | 8.7 × 109 |
| 2018 | 22 | 7.9 × 109 |
| February 2018 mobile sampling station | 16–68 (min-max) | — |
Induction of micronuclei by PM2.5 in human lymphocytes in vitro. N = 8.
| Test substance | Treatment Period Dose (h) (μg/ml) | BNCs scored | Distribution of BNCs according to the number of MNi | MNi | Ab.C | MNi/cell ± S.D. (%) | Ab.C/cell ± S.D. (%) | CBPI ± S.D. | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||||||||
| NC | — | — | 16,000 | 21 | 0 | 0 | 0 | 21 | 21 | 0.131 ± 0.026 | 0.131 ± 0.026 | 1.704 ± 0.053 |
| 0.1% DMSO | 48 | — | 16,000 | 30 | 0 | 0 | 0 | 30 | 30 | 0.188 ± 0.058 | 0.188 ± 0.058 | 1.576 ± 0.185 |
| MMC | 48 | 0.10 | 16,000 | 149 | 22 | 6 | 0 | 211 | 203 | 1.319 ± 0.324 | 1.269 ± 0.214 | 1.327 ± 0.049 *** |
| PM2.5 | 48 | 5 | 16,000 | 64 | 7 | 0 | 0 | 78 | 77 | 0.488 ± 0.203* | 0.481 ± 0.193* | 1.504 ± 0.156 |
| PM2.5 | 48 | 10 | 16,000 | 106 | 8 | 2 | 0 | 128 | 125 | 0.800 ± 0.220** | 0.781 ± 0.194** | 1.426 ± 0.126 |
| PM2.5 | 48 | 15 | 16,000 | 142 | 9 | 3 | 0 | 169 | 163 | 1.056 ± 0.387** | 1.019 ± 0.353** | 1.439 ± 0.041 |
| PM2.5 | 48 | 20 | 16,000 | 137 | 26 | 9 | 0 | 216 | 209 | 1.350 ± 0.387** | 1.306 ± 0.357** | 1.337 ± 0.078*** |
BNCs = Binucleated cells; MNi = micronuclei; Ab.C = Aberrant cells (cells with 1 or more MNi); NC = Negative Control;
MMC = Mitomycin-C; S.D. = Standard Deviation. CBPI = Cytokinesis-Block Proliferation Index.
*P = 0.003; **P < 0.001; ***P = 0.036 with respect to DMSO solvent control.
Figure 1Examples of observed bi-nucleated cells with micronuclei (A,B); tri-nucleated cell with micronucleus (C); tetra-nucleated cell with micronucleus (D); bi-nucleated cell with Nuclear Bud (E); and bi-nucleated cell cells with Nucleoplasmic Bridges (F). According to standardized procedures, micronuclei of tri- and tetra-nucleated cells were not scored in the evaluation of the total genomic damage. Photos were performed at 1000X magnification.
Induction of NPBs and NBUDs by PM2.5 in human lymphocytes in vitro. N = 8.
| Test substance | Treatment Period Dose (h) | BNCs scored | BNCs with NPBs ± S.D. (‰) | BNCs with NBUDs ± S.D. (‰) | |
|---|---|---|---|---|---|
| NC | — | — | 16,000 | 0.313 ± 0.259 | 0.563 ± 0.320 |
| 0.1% DMSO | 48 | — | 16,000 | 0.500 ± 0.267 | 0.813 ± 0.372 |
| MMC | 48 | 0.10 μg/mL | 16,000 | 2.188 ± 0.753 | 2.750 ± 1.165 |
| PM2.5 | 48 | 5 μg/mL | 16,000 | 0.750 ± 0.463 | 0.875 ± 0.518 |
| PM2.5 | 48 | 10 μg/mL | 16,000 | 1.125 ± 0.231* | 1.250 ± 0.378** |
| PM2.5 | 48 | 15 μg/mL | 16,000 | 1.188 ± 0.259* | 1.313 ± 0.259 *** |
| PM2.5 | 48 | 20 μg/mL | 16,000 | 1.250 ± 0.225* | 1.833 ± 0.516 * |
BNCs = Binucleated cells; NPBs = Nucleoplasmic Bridges; NBUDs = Nuclear Buds;
NC = Negative Control; MMC = Mitomycin-C; S.D. = Standard Deviation.
*P < 0.001; **P = 0.049; ***P = 0.021.
Multiple regression analysis between PM2.5 concentrations.
| Biomarker | β-co | 95% CI (Lower) – (Upper) | |
|---|---|---|---|
| MNi | 0.736 | (3.739)–(7.636) | <0.001 |
| Cells with MNi | 0.749 | (3.638)–(7.212) | <0.001 |
| NPBs | 0.440 | (0.074)–(0.551) | 0.012 |
| NBUDs | 0.628 | (0.310)–(0.840) | <0.001 |
MNi = Micronuclei; NPBs = nucleoplasmic bridges; NBUDs = nuclear buds.